258 related articles for article (PubMed ID: 23687445)
1. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Int J Nanomedicine; 2013; 8():1015-27. PubMed ID: 23687445
[TBL] [Abstract][Full Text] [Related]
2. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231).
Gurunathan S; Han J; Park JH; Kim JH
Int J Nanomedicine; 2014; 9():1783-97. PubMed ID: 24741313
[TBL] [Abstract][Full Text] [Related]
3. Green chemistry approach for the synthesis of biocompatible graphene.
Gurunathan S; Han JW; Kim JH
Int J Nanomedicine; 2013; 8():2719-32. PubMed ID: 23940417
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene.
Gurunathan S; Han JW; Park JH; Eppakayala V; Kim JH
Int J Nanomedicine; 2014; 9():363-77. PubMed ID: 24453487
[TBL] [Abstract][Full Text] [Related]
5. A Novel Biomolecule-Mediated Reduction of Graphene Oxide: A Multifunctional Anti-Cancer Agent.
Choi YJ; Kim E; Han J; Kim JH; Gurunathan S
Molecules; 2016 Mar; 21(3):375. PubMed ID: 26999102
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa.
Gurunathan S; Han JW; Dayem AA; Eppakayala V; Kim JH
Int J Nanomedicine; 2012; 7():5901-14. PubMed ID: 23226696
[TBL] [Abstract][Full Text] [Related]
7. Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.
Gurunathan S; Han JW; Kim ES; Park JH; Kim JH
Int J Nanomedicine; 2015; 10():2951-69. PubMed ID: 25931821
[TBL] [Abstract][Full Text] [Related]
8. An environmentally friendly approach to the reduction of graphene oxide by Escherichia fergusoni.
Gurunathan S; Han JW; Eppakayala V; Jeyaraj M; Kim JH
J Nanosci Nanotechnol; 2013 Mar; 13(3):2091-8. PubMed ID: 23755651
[TBL] [Abstract][Full Text] [Related]
9. Differential Immunomodulatory Effect of Graphene Oxide and Vanillin-Functionalized Graphene Oxide Nanoparticles in Human Acute Monocytic Leukemia Cell Line (THP-1).
Gurunathan S; Kang MH; Jeyaraj M; Kim JH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634552
[TBL] [Abstract][Full Text] [Related]
10. Intracellular localization and toxicity of graphene oxide and reduced graphene oxide nanoplatelets to mussel hemocytes in vitro.
Katsumiti A; Tomovska R; Cajaraville MP
Aquat Toxicol; 2017 Jul; 188():138-147. PubMed ID: 28521151
[TBL] [Abstract][Full Text] [Related]
11. Microbial reduction of graphene oxide by Escherichia coli: a green chemistry approach.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Colloids Surf B Biointerfaces; 2013 Feb; 102():772-7. PubMed ID: 23107955
[TBL] [Abstract][Full Text] [Related]
12. Reduced graphene oxide-silver nanoparticle nanocomposite: a potential anticancer nanotherapy.
Gurunathan S; Han JW; Park JH; Kim E; Choi YJ; Kwon DN; Kim JH
Int J Nanomedicine; 2015; 10():6257-76. PubMed ID: 26491296
[TBL] [Abstract][Full Text] [Related]
13. Biofabrication of Lysinibacillus sphaericus-reduced graphene oxide in three-dimensional polyacrylamide/carbon nanocomposite hydrogels for skin tissue engineering.
Narayanan KB; Choi SM; Han SS
Colloids Surf B Biointerfaces; 2019 Sep; 181():539-548. PubMed ID: 31185446
[TBL] [Abstract][Full Text] [Related]
14. Facile fabricating of rGO and Au/rGO nanocomposites using Brassica oleracea var. gongylodes biomass for non-invasive approach in cancer therapy.
Yousefimehr F; Jafarirad S; Salehi R; Zakerhamidi MS
Sci Rep; 2021 Jun; 11(1):11900. PubMed ID: 34099785
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro study of single and four layer graphene oxide nanoflakes - Cytotoxicity and cellular uptake.
Peruzynska M; Cendrowski K; Barylak M; Tkacz M; Piotrowska K; Kurzawski M; Mijowska E; Drozdzik M
Toxicol In Vitro; 2017 Jun; 41():205-213. PubMed ID: 28323107
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells.
Gurunathan S; Han JW; Eppakayala V; Dayem AA; Kwon DN; Kim JH
Nanoscale Res Lett; 2013 Sep; 8(1):393. PubMed ID: 24059222
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Colloids Surf B Biointerfaces; 2013 May; 105():58-66. PubMed ID: 23352948
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of reduced graphene oxide and its in-vitro cytotoxicity against cervical cancer (HeLa) cell lines.
Luo L; Xu L; Zhao H
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():198-202. PubMed ID: 28575975
[TBL] [Abstract][Full Text] [Related]
19. Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2.
Lammel T; Boisseaux P; Fernández-Cruz ML; Navas JM
Part Fibre Toxicol; 2013 Jul; 10():27. PubMed ID: 23849434
[TBL] [Abstract][Full Text] [Related]
20. In vitro toxicity evaluation of graphene oxide on A549 cells.
Chang Y; Yang ST; Liu JH; Dong E; Wang Y; Cao A; Liu Y; Wang H
Toxicol Lett; 2011 Feb; 200(3):201-10. PubMed ID: 21130147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
